A method for estimating duration of illness in alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 17, Issue 1-2, 2004, Pages 1-4

  Doody, Rachelle Smith ^a,c   Dunn, J Kay ^b   Huang, Eugene ^a   Azher, Shaheda ^a   Kataki, Maria ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Disease duration

Indexed keywords

ALZHEIMER DISEASE; CAREGIVER; CLINICAL FEATURE; DISEASE DURATION; HUMAN; LIFE EVENT; MEDICAL RECORD; PHYSICIAN; PRIORITY JOURNAL; REVIEW; STANDARDIZATION;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; CAREGIVERS; DISEASE PROGRESSION; GERIATRICS; HUMANS; INTERVIEWS; MEDICAL HISTORY TAKING;

EID: 0344629372     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074078     Document Type: Review

References (8)

1. Small GW, Kuhl DE, Fujikawa DG, Ashford W: Clinical characterization of Alzheimer's disease: Reliability of 'age at onset' and a new descriptor, 'age at shift.' J Geriatr Psychiatry Neurol 1988;1:207-211.
2. Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y: A standard technique for establishing onset and duration of symptoms of Alzheimer's disease. Arch Neurol 1995;52:961-966.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease. Neurology 1984;34: 939-944.
4. Roman G, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Yokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, Phil D, De Carli C, Culebras A, Korczyn AD, Bogousslavsky J, Harmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Neurology 1993;43:250-260.
5. Lin L: A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45: 255-268.
6. Donner A, Eliasziw M: Sample size requirements for reliability studies. Stat Med 1987;6: 441-448.
7. Doody RS, Massman P, Dunn JK: A method for estimating progression rates in Alzheimer's disease. Arch Neurol 2001;58:449-454.
8. Milliken JK, Edland S: Mixed effect models of longitudinal Alzheimer's disease data: A cautionary note. Stat Med 2000;19:1617-1629.